A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

NCT06706622 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: Amlenetug
DRUG: Placebo

Sponsor

H. Lundbeck A/S